Bill C-56, a new and inevitably controversial piece of proposed legislation, was introduced on March 1, 2013. With the short title, Combating Counterfeit Products Act,
The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In
It is my pleasure to return to my editorial duties (sans a 007 title pun) for the IPilogue to bring a first hand account of
The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer
The institution of a controversial new Cybercrime Prevention Act in the Philippines may leave plagiarists subject to criminal sanctions. The penalty for the plagiarism depends
The extremely variable pricing of diamonds has made them a historically difficult and unstable commodity to trade. However, recent advents in diamond technology have been
